Clinical trial
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in…
NCT00410072 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00410072 |
|---|---|
| Title | Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B |
| Official title | A Comparative Study of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy vs. Entecavir Monotherapy in Adults Who Are Treatment-Naive to Nucleosides and Nucleotides: The BE-LOW Study |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | Entecavir, Entecavir + Tenofovir |
| Enrollment | 669 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Dec 12, 2006 |
| Last update posted | Mar 15, 2013 |
| Countries | Argentina, Australia, Brazil, Canada, France, India, Italy, Mexico, Poland, Russia, South Africa, Turkey (Türkiye) and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: